PATENT CLAIM ANALYSIS

Application Number: 16044255
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-07
Patent Classification: ["514", "391000"]

Abstract:
This disclosure provides formulations of enzalutamide and their use for treating hyperproliferative disorders.

Claim (Index 19):
The pharmaceutical composition of  claim 7 , wherein the composition is in the form of a solid amorphous dispersion of enzalutamide and a concentration-enhancing polymer.

Metadata:
- Claim Count in Document: 55.0
- Percentile: 95.0
- Lexical Diversity: 1.0
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13843224', '13494668', '11799447', '10459808', '13610350']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7855940610642276
- 35 USC 102 Novelty (BERT): 0.5112922583540886
- Combined Prediction Score: 0.7581638807932137
- Mean Citation Score: 260.50458
- Max Citation Score: 271.86276000000004
- Similarity Product: 200.4428353508377

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test